Transcatheter aortic valve replacement and Candida parapsilosis endocarditis: a deadly combination

Susana Ortega-Silva, Willian A. Ortiz-Solis, Diego Neach de la Vega, Nilda Espinola-Zavaleta, America G. Urbina-Vazquez, Antonio R. Bailon-Sotelo, Abraham Villalobos-Flores
2019 Clinical Research and Trials  
Transcatheter aortic valve infective endocarditis is a life-threatening complication. Transcatheter aortic valve infective endocarditis (TAVIE) mortality caused by Candida parapsilosis is unknown. Clinical Case: We present a case of a 73-year-old female diagnosed with severe aortic stenosis secondary to bicuspid aortic valve and coronary artery disease with a significant lesion of the proximal left anterior descending artery, treated with one sirolimus-eluting stent and transcatheter aortic
more » ... catheter aortic valve replacement. A month later she began with persistent fever and hypotension. A transesophageal echocardiogram (TEE) showed vegetations adhered to the transcatheter aortic valve prosthesis with a moderate posterior paravalvular leak. Positive blood cultures were obtained with Candida parapsilosis isolation. She was treated with Amphotericin B plus voriconazole and underwent surgical aortic valve replacement. Unfortunately, surgery was complicated with aortic and coronary arteries dissection, cardiorespiratory arrest and death. The transesophageal echocardiography had an excellent correlation with surgical findings.
doi:10.15761/crt.1000276 fatcat:ee7z55bdlvcjjb73ctuy2z5jsq